Edesa Biotech, Inc. (EDSA)
NASDAQ·Healthcare·Biotechnology
$14.32
+28.20%
Mkt Cap $93.25M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 13, 2026 | — | — | — | -$0.28 | -$0.28 | +0.00% | — | — |
| Q4 2025 Dec 12, 2025 | — | — | — | -$0.27 | -$0.32 | -18.52% | — | — |
| Q3 2025 Aug 8, 2025 | — | — | — | -$0.26 | -$0.25 | +3.85% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.30 | -$0.30 | +0.00% | — | — |
| Q1 2025 Feb 14, 2025 | — | — | — | -$0.31 | -$0.48 | -54.84% | — | — |
| Q4 2024 Dec 13, 2024 | — | — | — | -$0.54 | -$0.29 | +46.30% | — | — |
| Q3 2024 Aug 9, 2024 | — | — | — | -$0.58 | -$0.52 | +10.34% | — | — |
| Q2 2024 May 10, 2024 | — | — | — | -$0.69 | -$0.58 | +15.94% | — | — |
| Q1 2024 Feb 9, 2024 | — | — | — | -$1.21 | -$0.54 | +55.37% | — | — |
| Q4 2023 Dec 15, 2023 | — | -$1.12M | — | -$0.71 | -$0.60 | +15.49% | — | — |
| Q3 2023 Aug 9, 2023 | — | — | — | -$1.19 | -$0.70 | +41.18% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$1.19 | -$0.84 | +29.41% | — | — |
| Q1 2023 Feb 10, 2023 | — | $1.12M | — | -$1.33 | -$0.91 | +31.58% | — | — |
| Q4 2022 Dec 16, 2022 | — | — | — | -$2.80 | -$0.07 | +97.50% | — | — |
| Q3 2022 Aug 12, 2022 | — | — | — | -$2.52 | -$2.59 | -2.78% | — | — |
| Q2 2022 May 13, 2022 | — | — | — | -$2.59 | -$2.31 | +10.81% | — | — |
| Q1 2022 Feb 14, 2022 | — | — | — | -$2.80 | -$2.31 | +17.50% | — | — |
| Q4 2021 Dec 28, 2021 | — | -$3.51M | — | -$2.59 | -$1.89 | +27.03% | — | — |
| Q3 2021 Aug 13, 2021 | — | — | — | -$2.24 | -$2.52 | -12.50% | — | — |
| Q2 2021 May 14, 2021 | — | — | — | -$2.10 | -$1.33 | +36.67% | — | — |